SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-004974
Filing Date
2017-01-20
Accepted
2017-01-20 17:57:46
Documents
2
Period of Report
2017-01-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1582
2 POA DOCUMENT poa.txt EX-24.3_696121 3893
  Complete submission text file 0001209191-17-004974.txt   6899
Mailing Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139 617-401-0011
Dimension Therapeutics, Inc. (Issuer) CIK: 0001592288 (see all company filings)

IRS No.: 463942159 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O DIMENSION THERAPEUTICS, INC. 840 MEMORIAL DRIVE 4TH FLOOR CAMBRIDGE MA 02139
Business Address
Hohneker John (Reporting) CIK: 0001695378 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37601 | Film No.: 17539456